Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析

◆英語タイトル:Matrix Composites & Engineering Ltd (MCE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE258941FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Matrix Composites & Engineering Ltd (Matrix) is a manufacturer and supplier of engineered products and services. The company manufactures and distributes engineered products for developing and utilizing advanced composite and polymer materials technologies. Its products include well construction equipment, riser buoyancy system, buoyancy system, installation buoyancy system, lightweight panel systems, syntactic structural systems, functional fillers, syntactic structural systems, energy absorption systems, floating concrete, moulded pipe cryogenic insulation products, composite pipe reinforcement systems, and structural dampening systems, among others. Matrix offers riser management, riser maintenance and rentals, installation, integrated well services and offshore services. The company has operations in Australia, Korea, Singapore, the UK and the US. Matrix is headquartered in Perth, Western Australia, Australia.

Matrix Composites & Engineering Ltd Key Recent Developments

Feb 03,2021: Matrix awarded technology development contract by Newcrest Discover
Feb 01,2021: Matrix awarded technology development contract by Newcrest
Dec 04,2020: Matrix signs technology development agreement with Woodside
May 27,2020: ITT Matrix composites’ HiRPM technology adopted into lockheed Martin’s F-35 lightning program

This comprehensive SWOT profile of Matrix Composites & Engineering Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Matrix Composites & Engineering Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Matrix Composites & Engineering Ltd – Key Information
Matrix Composites & Engineering Ltd – Overview
Matrix Composites & Engineering Ltd – Key Employees
Matrix Composites & Engineering Ltd – Key Employee Biographies
Matrix Composites & Engineering Ltd – Key Operational Heads
Matrix Composites & Engineering Ltd – Major Products and Services
Matrix Composites & Engineering Ltd – History
Matrix Composites & Engineering Ltd – Company Statement
Matrix Composites & Engineering Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Matrix Composites & Engineering Ltd – Business Description
Matrix Composites & Engineering Ltd – Corporate Strategy
Matrix Composites & Engineering Ltd – SWOT Analysis
SWOT Analysis – Overview
Matrix Composites & Engineering Ltd – Strengths
Matrix Composites & Engineering Ltd – Weaknesses
Matrix Composites & Engineering Ltd – Opportunities
Matrix Composites & Engineering Ltd – Threats
Matrix Composites & Engineering Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Matrix Composites & Engineering Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Matrix Composites & Engineering Ltd, Key Information
Matrix Composites & Engineering Ltd, Key Ratios
Matrix Composites & Engineering Ltd, Share Data
Matrix Composites & Engineering Ltd, Major Products and Services
Matrix Composites & Engineering Ltd, History
Matrix Composites & Engineering Ltd, Key Employees
Matrix Composites & Engineering Ltd, Key Employee Biographies
Matrix Composites & Engineering Ltd, Key Operational Heads
Matrix Composites & Engineering Ltd, Other Locations
Matrix Composites & Engineering Ltd, Subsidiaries

Matrix Composites & Engineering Ltd, Key Competitors
Matrix Composites & Engineering Ltd, SWOT Analysis
Matrix Composites & Engineering Ltd, Ratios based on current share price
Matrix Composites & Engineering Ltd, Annual Ratios
Matrix Composites & Engineering Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Simona AG (SIM):企業の財務・戦略的SWOT分析
    Summary Simona AG (Simona) is a chemical company that manufactures and distributes chemicals and thermoplastic products. The company offers products such as pipes and fittings, semi-finished products, and finished parts, among others. Its semi-finished plastics include profiles, plates, rods, and we …
  • Lowe’s Companies, Inc.:戦略・SWOT・企業財務分析
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • RPG Cables Limited:企業の戦略・SWOT・財務情報
    RPG Cables Limited - Strategy, SWOT and Corporate Finance Report Summary RPG Cables Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • St. Barbara Limited:企業のM&A・事業提携・投資動向
    St. Barbara Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's St. Barbara Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • EMS SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EMS SA (EMS) is a pharmaceutical company, which is focused in the development of products for improvement of health and well-being of the population. It operates in prescription segments generics, branded pharmaceuticals, OTC and hospital. It has presence in the US market through Brace Pharm …
  • Wirecard AG:企業のM&A・事業提携・投資動向
    Wirecard AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wirecard AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Genmab AS (GMAB):企業の財務・戦略的SWOT分析
    Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Crown Bioscience Inc (6554):製薬・医療:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • GenSight Biologics SA (SIGHT):製薬・医療:M&Aディール及び事業提携情報
    Summary GenSight Biologics SA (GenSight) is a clinical stage biotechnology company that discovers and develops novel therapies for mitochondrial and neurodegenerative diseases. The company’s product pipeline comprises GS010 and GS030 developed for the treatment of retinal degenerative diseases. It d …
  • Genethon SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Genethon SA (Genethon) is a non-profit biotherapy research and development organization which designs and develops gene therapy products for rare diseases. The company is developing gene therapy products for the treatment of limb girdle myophaties, duchenne muscular dystrophy, myotubular myo …
  • Firestone Diamonds plc:企業の戦略・SWOT・財務情報
    Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AngloGold Ashanti Ltd:企業のM&A・事業提携・投資動向
    AngloGold Ashanti Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AngloGold Ashanti Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Franklin Street Properties Corp:企業の戦略・SWOT・財務分析
    Franklin Street Properties Corp - Strategy, SWOT and Corporate Finance Report Summary Franklin Street Properties Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Zymeworks Inc (Zymeworks) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of biotherapeutics for the treatment of cancer, autoimmune and inflammatory diseases. Its pipeline products include ZW25 and ZW49, novel bispecific antibodies …
  • Applied DNA Sciences Inc (APDN):企業の財務・戦略的SWOT分析
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company offers products such as DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DN …
  • First Light Biosciences Inc:企業の製品パイプライン分析2018
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • WAVE Life Sciences Ltd (WVE)-製薬・医療分野:企業M&A・提携分析
    Summary WAVE Life Sciences Ltd (WAVE), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, among ot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆